ATOS insider filings
ATOSSA THERAPEUTICS, INC. — 43 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-05-14. Screen ATOS transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ATOS between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — ATOSSA THERAPEUTICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | Chen Shu-Chih — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-05-14 | 4 | Remmel H. Lawrence — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-05-14 | 4 | Finn Jonathan — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-05-14 | 4 | Galli Stephen J — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-05-14 | 4 | Cigler Tessa — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-05-14 | 4 | Steinhart Richard I — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-03-31 | 4 | QUAY STEVEN C — President & CEO, Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2026-03-30 | 4 | Daniel Mark James — Chief Financial Officer | Grant/award (A): 63,000 @ $0 | EDGAR |
| 2026-01-30 | 4/A | QUAY STEVEN C — President & CEO, Director | Grant/award (A): 331,674 @ $0 · Grant/award (A): 950,000 (derivative) @ $0.60 | EDGAR |
| 2026-01-22 | 4 | QUAY STEVEN C — President & CEO, Director | Grant/award (A): 325,203 @ $0 · Grant/award (A): 950,000 (derivative) @ $0.60 | EDGAR |
| 2025-10-21 | 4 | Daniel Mark James — Chief Financial Officer | Grant/award (A): 578,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | QUAY STEVEN C — President & CEO, Director | Purchase (P): 11,239 @ $0.88 | EDGAR |
| 2025-05-16 | 4 | Finn Jonathan — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Chen Shu-Chih — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Rees Heather — Chief Financial Officer | Grant/award (A): 543,785 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Galli Stephen J — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Remmel H. Lawrence — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Cigler Tessa — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Steinhart Richard I — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | QUAY STEVEN C — President & CEO, Director | Grant/award (A): 1,366,062 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Remmel H. Lawrence — Director | Purchase (P): 10,000 @ $0.70 | EDGAR |
| 2024-07-01 | 4 | Finn Jonathan — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Remmel H. Lawrence — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Chen Shu-Chih — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Rees Heather — SVP, Finance and Accounting | Grant/award (A): 577,700 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Galli Stephen J — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Cigler Tessa — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Steinhart Richard I — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | QUAY STEVEN C — President & CEO, Director | Grant/award (A): 1,795,100 (derivative) @ $0 | EDGAR |
| 2024-04-11 | 4 | Finn Jonathan — Director | Purchase (P): 25,000 @ $1.77 | EDGAR |
| 2024-03-14 | 4 | Cigler Tessa — Director | Grant/award (A): 20,834 (derivative) @ $0 | EDGAR |
| 2023-11-17 | 4 | WEAVER GREGORY L — Former EVP, CFO, & Director, Director | Sale (S): 50,000 @ $0.65 | EDGAR |
| 2023-11-15 | 4 | Finn Jonathan — Director | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2023-11-15 | 4/A | Finn Jonathan — Director | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | WEAVER GREGORY L — EVP & CFO, Director | Purchase (P): 50,000 @ $0.97 | EDGAR |
| 2023-06-05 | 4 | WEAVER GREGORY L — EVP & CFO, Director | Grant/award (A): 2,600,000 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | Remmel H. Lawrence — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | Chen Shu-Chih — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | Galli Stephen J — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | Steinhart Richard I — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | WEAVER GREGORY L — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | Guse Kyle — CFO, Gen Counsel and Secretary | Grant/award (A): 557,900 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | QUAY STEVEN C — President & CEO, Director | Grant/award (A): 1,873,100 (derivative) @ $0 | EDGAR |
Recent 8-K events — ATOSSA THERAPEUTICS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-08 | 8-K | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-25 | 8-K | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ATOS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →